"Medicine regulatory authorities in the US have updated the product information for ddI (didanosine, Videx) to warn that treatment with the drug can cause a serious liver problem.
"A communication was circulated by the Food and Drug Administration (FDA) on January 29th stating that the label for ddI would be altered and caution that the drug can cause non-cirrhotic portal hypertension."
Read more in Aidsmap, February 1, 2010.
0 comments:
Post a Comment